Trademark Overview
On Wednesday, January 21, 2026, a trademark application was filed for V VERISIAN with the United States Patent and Trademark Office. The USPTO has given the V VERISIAN trademark a serial number of 99607750. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, January 21, 2026. This trademark is owned by Verisian Ltd. The V VERISIAN trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:
Scientific and technological services relating to clinical research; software development for trial data analysis and validation; Scientific research and analysis services in the field of pharmaceuticals and biotechnology; Preparation of scientific reports; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Scientific research for medical purposes; Provision of scientific information; Software development tools for clinical research; Programming software for importing and managing data; Data management and analytics services for clinical trials; Software as a service (SaaS) featuring software incorporating artificial intelligence (AI) tools for data validation, data analytics, machine learning and artificial intelligence; Software as a service (SaaS) featuring software for clinical trial analysis; Software as a service (SaaS) featuring software for data validation and regulatory submission; Development of databases used in clinica...
Consultancy services in relation to medical regulatory reviews; Medical regulatory review services; Medical analysis services relating to the treatment and validation of clinical trial data; Medical information services provided via digital platforms; Issuing and compilation of medical reports; Monitoring of medical data for medical diagnosis and treatment; Providing pharmaceutical information; Provision of medical data analysis services for diagnostic and treatment purposes; Medical data analysis and validation services to support regulatory submissions and approval; Preparation of medical reports based on biometric and clinical data; Advisory services relating to patient access to clinical innovations; Support services for public health authorities in evaluating medical data